XML 156 R35.htm IDEA: XBRL DOCUMENT v3.25.1
Segment Reporting (Tables)
3 Months Ended
Mar. 31, 2025
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment

Financial information relating to our reportable operating segments and reconciliations to the consolidated totals for the three-month periods ended March 31, 2025 and 2024, were as follows (in thousands):

Three Months Ended

Three Months Ended

March 31, 2025

March 31, 2024

  

Cardiovascular

  

Endoscopy

  

Consolidated

  

Cardiovascular

  

Endoscopy

  

Consolidated

Net sales

 

$

338,713

 

$

16,638

 

$

355,351

 

$

313,374

$

10,134

 

$

323,508

Cost of sales standard(1)

138,440

4,363

133,066

3,109

Cost of sales other(2)

 

37,784

 

2,744

 

 

35,302

 

316

 

Selling, general and administrative expenses

 

100,974

 

6,512

 

 

91,300

 

3,128

 

Research and development expenses

21,954

524

20,916

566

Other operating expenses(3)

1,023

(117)

Income from operations

$

38,538

$

2,495

$

41,033

$

32,907

$

3,015

$

35,922

Total other expense — net

(3,075)

(1,574)

 

  

 

  

 

  

 

  

 

  

 

  

Income before income taxes

 

$

37,958

 

$

34,348

(1)Cost of sales standard represents costs of goods sold measured at the internal standard cost for production of inventory. Inventory standard costs include material, labor and manufacturing overhead.
(2)Cost of sales other for all segments includes amortization expense associated with our developed technology and license agreements intangible assets, freight and handling associated with shipments to customers, provisions based on estimated excess, slow moving and obsolete inventories, manufacturing and price variances, and royalties.
(3)Other operating expenses include contingent consideration expense (benefit) related to the changes in fair value of contingent payments associated with acquisitions.

Total depreciation and amortization by operating segment for the three-month periods ended March 31, 2025 and 2024, consisted of the following (in thousands):

Three Months Ended

March 31, 

2025

2024

Cardiovascular

$

26,970

$

23,388

Endoscopy

2,322

211

Total

$

29,292

$

23,599